Live Breaking News & Updates on Ovid 19 vaccine india

Stay informed with the latest breaking news from Ovid 19 vaccine india on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ovid 19 vaccine india and stay connected to the pulse of your community

COVID-19 vaccine: Over 14.68 cr doses still available with states, UTs

More than 14.68 crore (14,68,60,146) — balance and unutilised — vaccine doses are still available with the states and union territories, the Union health ministry said.

Covid-19-vaccine , Ovid-19-vaccine-doses , Ovid-19-vaccine-india , Ovid-19-vaccine-doses-india , Ovid-19-vaccine-doses-with-states , Ovid-19-vaccine-doses-with-uts , Ovid-19-vaccination , Ovid-19-vaccination-drive , Ovid-19-vaccination-india , Ovid-19-vaccination-drive-india ,

Covaxin likely to get emergency approval after WHO committee's meeting today

Covaxin likely to get emergency approval after WHO committee’s meeting today - Covaxin is likely to get the emergency use approval by WHO today after the meeting of the technical advisory committee.

Hyderabad , Andhra-pradesh , India , Bharat , Soumya-swaminathan , Health-emergencies-programme-dr-mike-ryan , World-health-organisation , Bharat-biotech , Emergencies-programme-dr-mike-ryan , Drugs-controller-general , Ho , Ovaxin

US gave only 7.5 mn doses of Covid-19 vaccine to India, needs to do more: Krishnamoorthi

Indian-American Congressman Raja Krishnamoorthi's statement came on a day when the White House said it is “eager” to continue the partnership with India in the fight against coronavirus

United-states , India , White-house , District-of-columbia , Raja-krishnamoorthi , Jeff-merkley , Pramila-jayapal , Elizabeth-warren , Joe-biden , Response-programme-panpre , Health-resources , Vaccine-alliance

COVID-19 vaccine: 3.56 doses bought by private hospitals till Aug 2, says Centre

Minister of State for Health Bharati Pravin Pawar said from May 1 to June 20, the 'Liberalised Pricing and Accelerated National COVID-19 Vaccination Strategy'' was implemented to incentivise production by vaccine manufacturers

India , Lok-sabha , Guidelines-for-implementation-of-national , Vaccination-program , Health-bharati-pravin-pawar , Liberalised-pricing , Accelerated-national , Revised-guidelines , Covid-19-vaccine , Ovid-19-vaccine-india , Ndia-covid-19-vaccine , Ndia-covid-19-vaccine-doses

Experts question Centre's one-dose Covid vaccination efficacy theory

The Centre's idea of single-dose vaccination comes at a time when the UK has decided to reduce the dosage interval of the AstraZeneca vaccine to eight weeks to ensure full protection of its vulnerable population.

Karnataka , India , United-kingdom , Banaras , Uttar-pradesh , Scotland , Bharat , Aviral-vatsa , Gyaneshwer-chaubey , Giridhar-babu , Astrazeneca , Astrazeneca-oxford-university

Nearly 12 crore vaccine doses to be available for national Covid vaccination in June: Govt

According to the data released by the Union health ministry, nearly 12 crore doses of Covid-19 vaccine will be made available to states and UTs in June for the national Covid-19 vaccination programme in the country.

Delhi , India , Union-territories , National-covid , Ministry-of-health , Ministry-of-health-mo , Family-welfare , Liberalised-pricing , Accelerated-national , Covid-vaccine , Ovid-vaccine-india

300% More Antibodies After Delaying Second Dose of COVID-19 Vaccine, Says Study

New Delhi:
More countries are turning to a once-controversial approach that has now been confirmed by scientific studies: doubling or tripling the time between the first and second Covid vaccine doses.
Delaying the second shot not only helps the current supply of shots to be spread more widely but also increases the defensive strength of the first inoculation by allowing the immune system more time to react to it. According to new research, levels of antibodies developed to combat the virus are 20 percent to 300 percent higher when the follow-up vaccine is given later.
That's good news for countries like Singapore, which is dealing with an unusual, but minor, increase in cases following last year's successful containment of the virus. To meet a target of covering the entire adult population with at least one shot by the end of August, the city-state is now expanding dose periods from three to four weeks to six to eight weeks.

India , United-kingdom , New-delhi , Delhi , Singapore , National-university-of-singapore , Singapore-general , Dibrugarh , Assam , Poland , Canada , Canadian

Bharat Biotech caps Covaxin price, Rs 600 for states, Rs 1200 for private hospitals

Highlights
Bharat Biotech has also decided to export Covaxin, whose export prices will range between $15-20.
The vaccine maker said it is “deeply concerned by the ongoing COVID-19 pandemic in India and the world.”
The government will start the COVID-19 vaccination for all 18 years and above from May 1.
New Delhi: Bharat Biotech on Saturday (April 24) announced that it will provide its COVID-19 vaccine Covaxin to all state governments at Rs 600 per dose while for private hospitals the cost will be Rs 1200 per dose.
In its statement, the Hyderabad-based vaccine manufacturer said, "Following the Govt of India directives, we announce the prices of COVAXIN vaccines - ₹600 per dose for state hospitals and ₹1,200 per dose for private hospitals.”

India , Hyderabad , Andhra-pradesh , New-delhi , Delhi , Bharat , Union-ministry-of-health , Bharat-biotech , Union-ministry , Ovaxin , Ovid-19

COVID-19 India: COVID-19 vaccine delivery in India by drones possible

Image: CDSpace Robotics Pvt Ltd.
COVID-19 vaccine in India could soon be delivered by drones as the Indian Council of Medical Research (ICMR) in partnership with the Indian Institute of Technology (IIT) is preparing to conduct a study on the feasibility of the delivery of COVID-19 vaccine delivery using drones. Also Read - 5 Medical Gadgets you must have at home amid COVID-19 crisis: Oximeter to Blood pressure monitor
The development comes as the Center has announced that the vaccination against COVID-19 for those above 18 years will begin across India from May 1, 2021, as part of the third phase of the inoculation drive in the country. Also Read - COVID-19 vaccine registration for 18 years+ begins on April 28: How to book appointment online

Dehradun , Uttaranchal , India , Kanpur , Uttar-pradesh , Rudrapur , West-bengal , Katni , Orissa , Bharat , Nagar-nigam , Haldwani-haridwar

COVID vaccine data: How many people tested positive after first and second dose?

COVID vaccine data: How many people tested positive after first and second dose?
As per the data, more than 21,000 people tested positive for COVID-19 after taking the first dose of either Covishield or Covaxin.
Share
Updated: Apr 21, 2021, 09:45 PM IST
The government on Wednesday shared data of the number of people who tested positive for novel coronavirus after receiving the first and second dose of Covid-19 vaccines - Covaxin and Covishield.
As per the data, more than 21,000 people tested positive for COVID-19 after taking the first dose of either Covishield or Covaxin, while over 5,500 contracted the infection after taking the second dose, the Centre said.

Balram-bhargava , Indian-council-of-medical-research , Indian-council , Medical-research , General-balram-bhargava , Covid-19-vaccine , Ovid-19-vaccine-india , Ovid-19-vaccine-news , Ovid-data , Ovaxin-vaccine , Ovishield-vaccine , Cmr